⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3673998 | 0.74 | KDM4E (0.54) | — | |
| SCHEMBL765184 | 0.72 | — | — | |
| SCHEMBL18914327 | 0.72 | — | — | |
| SCHEMBL20886067 | 0.72 | — | — | |
| SCHEMBL217344 | 0.72 | — | — | |
| SCHEMBL3456377 | 0.72 | — | — | |
| SCHEMBL236034 | 0.72 | — | — | |
| SCHEMBL2140092 | 0.72 | — | — | |
| SCHEMBL17768549 | 0.72 | KDM4E (0.35) | — | |
| SCHEMBL14872282 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717382-B | Porphyrin and pyrimidine based high-density metallized covalent triazine polymer and preparation method and application thereof | 浙江工业大学 | 2022-08-19 | — | — | CN | claimed |
| CN-113717382-A | Porphyrin and pyrimidine-based high-density metallized covalent triazine polymer and preparation method and application thereof | 浙江工业大学 | 2021-11-30 | — | — | CN | claimed |
| CN-106866699-A | A kind of RTIs of diaryl thienopyrimidines HIV 1 and its preparation method and application | 山东大学 | 2017-06-20 | — | — | CN | claimed |
| EP-2507243-B1 | SPIROINDOLINONE PYRROLIDINES | HOFFMANN LA ROCHE (CH) | 2015-06-10 | — | — | EP | claimed |
| CN-102276537-B | Preparation method of 2-cyan-5-amiopyrimidine | UNIV SHANXI | 2013-01-23 | — | — | CN | claimed |
| EP-2507243-A1 | SPIROINDOLINONE PYRROLIDINES | F. Hoffmann-La Roche AG (CH) | 2012-10-10 | — | — | EP | claimed |
| US-20260090270-A1 | ORGANIC ELECTRONIC ELEMENT AND COMPOUND | TOSOH CORPORATION (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4334298-B1 | UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER | SCORPION THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4638445-A1 | 1,2,4-THIAZOLIDIN-3-ONE-1,1-DIOXIDE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE | Bristol-Myers Squibb Company (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4626191-A1 | ORGANIC ELECTRONIC ELEMENT AND COMPOUND | Tosoh Corporation (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-20250250259-A1 | METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. | 2025-08-07 | — | — | US | disclosed |
| CN-120167151-A | Organic electronic component and compound | 东曹株式会社 | 2025-06-17 | — | — | CN | disclosed |
| US-12312341-B2 | Methods for treating cancer | SCORPION THERAPEUTICS, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| WO-2011067185-A1 | SPIROINDOLINONE PYRROLIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-09 | — | — | WO | disclosed |
| US-20110130398-A1 | SPIROINDOLINONE PYRROLIDINES | BARTKOVITZ DAVID JOSEPH | 2011-06-02 | — | — | US | disclosed |
| US-7235559-B1 | Therapeutic quinazoline derivatives | ASTRAZENECA AB (SE) | 2007-06-26 | — | — | US | disclosed |
| EP-1218355-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001021597-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-03-29 | — | — | WO | disclosed |
| US-4997667-A | Pyridinyl compounds of N-carbamoyl-N-thiocarbamoyl- or N-amidino-glycine or beta-alanine useful as sweetening agents | UNIVERSITE CLAUDE BERNARD (FR) | 1991-03-05 | — | — | US | disclosed |
| EP-0321369-A1 | Heterocyclic sweeteners derived from N-carbamoyl-, N-thiocarbamoyl or N-amidino-glycine or beta-alanine | UNIVERSITE CLAUDE BERNARD - LYON 1 (FR) | 1989-06-21 | — | — | EP | disclosed |